National Consensus Meeting to Decide Outcome Measures for Adults with SMA

On September 9th and 10th in Ottawa, Ontario, 14 adult SMA experts including, clinicians, allied health care providers, patient organization representatives, and the Canadian Neuromuscular Disease Registry (CNDR) representatives gathered to reach an updated national consensus on outcome measures for adults with SMA. With increasing experience following adults on novel disease-modifying therapy alongside advances in standardized outcome measures, it was essential to revisit the prior Canadian adult SMA toolkit (2020, link), with a renewed emphasis on meaningful outcomes for patients. The consensus work will help to support discussions within individual provinces to understand response to therapy, advocate for appropriate access to high-cost therapeutics, and enable national comparisons. 

 

During this multi-day meeting, the group considered a broad spectrum of outcome measures that may be applicable to adult SMA to determine a core set of recommended, suggested, and exploratory measures, based on the individual’s current functional status. To support measure selection, patient preferences and perspectives, practitioner experiences, feasibility (including time and equipment needed), and provincial payer requirements were discussed.  

 

The meeting concluded with a vote to determine which outcome measures should be completed across Canada for adults with SMA, and consensus was reached. Based on the new consensus results, the CNDR will update its SMA dataset accordingly.  Official results from this national consensus-building meeting will be released soon.  

CNDR logo4x3

Read next...

Journal of neuromuscular diseases

Journal of Neuromuscular Diseases Celebrates 10-Year Anniversary with Commemorative Editorial

The January 2024 edition of the Journal of Neuromuscular Diseases (JND) marked the journal’s 10-year anniversary!

Canadian Neuromuscular Community of Practice

NMD4C and MDC Announce Plans for Neuromuscular Community of Practice

We are thrilled to announce a new neuromuscular Community of Practice (CoP) initiative for neuromuscular healthcare providers! Our CoP will address the need for a centralized hub for neuromuscular HCPs, fostering collaboration, knowledge exchange, and skill enhancement to elevate NMD research and care across Canada. 

NMD4C investigators' research named to Quebec Science Magazine's top 10 discoveries of 2023

NMD4C Investigators’ Research Named to Quebec Science Magazine’s Top 10 Discoveries of 2023

The 31st edition of the Quebec Science magazine’s Top 10 Discoveries of the Year has recognized a publication from NMD4C investigators in their 2023 list of top scientific discoveries from Québec-based researchers. 

Defeat Duchenne grant $17 million over 29-years to fund promising Duchenne research.

Defeat Duchenne Canada Announce 2023-2024 Research Grants

Defeat Duchenne Canada, announce that it will grant $880,320 toward five promising research projects this year.

NMD4C welcomes two new staff members - Marine Christin, PhD and Maria Masnata, PhD

NMD4C Welcomes Two New Staff Members

The NMD4C recently welcomed two new members to the network coordination team! Marine Christin, PhD joins us as the new Pre-Clinical Science Coordinator, and Maria Masnata, PhD joins as the Clinical Trials & Community Practice Manager. 

Congratulations to the 2024 neuromuscular clinical and post-doctoral fellowship recipients. Photos of the fellows with information about their research insitutions.

2024 Recipients of NMD4C and MDC Neuromuscular Fellowship Funding Competition

The Neuromuscular Disease Network for Canada (NMD4C) together with Muscular Dystrophy Canada (MDC) are thrilled to announce the recipients of the National Clinical and Post-doctoral Fellowships funding competition.